Indeed, increased glycerol turnover that occurs due to increased adipose tissue lipolysis in obesity and diabetes may be a mechanism by which these conditions can activate hepatic ChREBP independently of dietary carbohydrate consumption (57, 58, 68, 69). Here, MLXIPL is linked to obesity disorder.